Clinical Trial: Safety, Blood Levels and Effects of AUT00201 in Patients With MEAK
Study Status: Completed
Recruit Status: RECRUITING
Condition: Myoclonus Epilepsies, Progressive
Study Type: INTERVENTIONAL
Official Title: A Randomized, Double-blind, Placebo-controlled, Crossover Study of the Effects of Single Doses of AUT00201 in Patients With Myoclonus Epilepsy and Ataxia Due to Potassium (K+) Channel Mutation (MEAK)
Brief Summary:
A randomized, double-blind, placebo-controlled, crossover study to assess the safety, tolerability, and pharmacokinetics of single doses of AUT00201 at 100 mg or matching placebo in patients with myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK).
Read more